| Date | Title | Description |
| 19.06.2024 | GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments | SEOUL, South Korea, June 19, 2024 /PRNewswire/ -- GenKOre, a pioneer in gene editing technology with its proprietary hypercompact CRISPR, known as TaRGET, is pleased to announce a strategic collaboration with Revvity's Gene Delivery franchi... |
| 18.06.2024 | GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments | SEOUL, South Korea, June 18, 2024 /PRNewswire/ -- GenKOre, a pioneer in gene editing technology with its proprietary hypercompact CRISPR, known as TaRGET, is pleased to announce a strategic collaboration with Revvity's Gene Delivery franchi... |
| 02.08.2022 | GenKOre develops hypercompact base editing system | DAEJEON, South Korea , Aug. 2, 2022 /PRNewswire/ -- GenKOre (homepage: www.genkore.com), a biotech start-up in Korea, had a study on the development of hypercompact adenine base editors (ABEs) published on Nature Chemical Biology on August ... |
| 02.08.2022 | GenKOre develops hypercompact adenine base editors (ABEs) | DAEJEON, South Korea, Aug. 2, 2022 /PRNewswire/ -- GenKOre, a biotech start-up in Korea, succeeded in the development of ABEs based on its own hypercompact gene-editing technology and had the relevant study published on Nature Chemical Biol... |
| 21.10.2021 | A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy. | DAEJEON, South Korea, Oct. 21, 2021 /PRNewswire/ -- On September 2, 2021, a scientific paper from GenKOre on the new hypercompact CRISPR system called CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF 54.9), one ... |
| 20.10.2021 | A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy. | DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a scientific paper from GenKOre on the new hypercompact CRISPR system called CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF 54.9), one ... |
